SerImmune

About SerImmune

Serimmune is an immune intelligence company that provides a comprehensive view of how the body responds to pathogens and other environmental factors. The company operates in the biotechnology sector, focusing on immune mapping technology to identify the entire repertoire of targets or antigens against which the immune system generates antibodies. These antigens come from a diverse range of sources, including pathogens, allergens, foods, and human tissues in cases of autoimmune disease and cancer.

Serimmune's primary clients include healthcare providers, research institutions, and pharmaceutical companies. The company leverages its digital serology platform to connect individual antibodies to their stimulating epitopes, providing valuable insights into immune responses. This platform is particularly useful for developing diagnostics, vaccines, and therapeutics, including those for SARS-CoV-2 (COVID-19).

The business model is based on offering immune mapping services and solutions to its clients, generating revenue through service fees, partnerships, and licensing agreements. By providing a high-resolution picture of immune responses, Serimmune aims to uncover factors that impact health and wellness, ultimately improving patient outcomes.